Winning Ideas

Nurturing grassroots ideas has resulted in incredible impact over the years

The Astellas Oncology C3 Prize sparks growth of innovative developments in cancer care - explore all of our winners 2016-2018.

If you’re interested in this year’s focus, see our About page.

Past Grand Prize Winners

Ebele Mbanugo

2018 Grand Prize Winner

Ebele Mbanugo

Idea: Produce timely, culturally relevant, entertaining information via a first-of-its-kind digital audio series with local actors that addresses common barriers to and myths of breast cancer treatment, which are of value to patients in Nigeria.

Learn more
Hernâni Oliveira

2017 Grand Prize Winner

Hernâni Oliveira

Idea: An augmented reality app to help solve common issues faced by pediatric patients and their parents around both education and physical engagement.

Learn more
Diane Jooris

2016 Grand Prize Winner

Diane Jooris

Idea: Virtual reality systems to help patients by providing anxiety and pain self-management tools.

Learn more

2018 Winners

Do Hyun Kim

2018 Support Tools Winner

Do Hyun Kim, Olga Romanova, Emily Dahl, Calvin Marambo, Anna Raheem

Idea: Outpatient wearable device designed to take body temperature readings of pediatric cancer patients at specific time intervals and inform them about the severity of their condition via an LED and sound feedback system to help decrease rates of infection-caused mortality in low- and middle-income countries.

Learn more
Richard Levenson

2018 Technology Winner

Richard Levenson

Idea: Update the microscope to provide diagnostic-quality images, with enhanced information, directly and quickly from fresh or fixed tissue to relieve both the requirement to first have access to histology and the time-consuming and costly processes involved.

Learn more

Learn more about past C3 Prize winners

2017 Winners

Kevin Bambury

2017 First Prize Winner

Kevin Bambury, Killarney, Ireland

Kevin is the co-founder of ONCOassist, which has developed an interactive informational app designed to contain all of the tools oncology professionals need at point of care to help diagnose and manage treatment.

ONCOassist aims to give professionals access to reliable and approved medical information to help them make the right decisions for patients in an increasingly complex oncology environment.

"We will use the funds to bring ONCOassist through the FDA approval process and become the first oncology calculator app to have this approval. We will also leverage the prestige of the C3 Prize to drive user growth within the US market."

Howard Isenstein

2017 First Prize Winner

Howard Isenstein, Bethesda, Maryland
Care Progress

Howard is the founder of Care Progress, whose app, CarePrompter, aims to improve patient navigation, adherence, and care coordination by prompting patients to check in with their clinicians frequently on a wide range of topics.

CarePrompter is designed to reduce inefficiencies in care delivery for patients and caregivers, while maintaining open channels of communication to ensure patient needs are being met.

"We plan to use the C3 Prize to improve the ability of our CarePrompter technology to detect when oncology patients are experiencing or likely to experience negative care trajectories by creating machine-learning derived algorithms to generate risk scores related to patients’ likelihood of being admitted to the emergency room."

Watch his 2017 application video.

Corey Kidd

2017 First Prize Winner

Cory Kidd, San Francisco, California
Catalia Health

Cory is the CEO of Catalia Health, which has developed the Mabu Wellness Coach Platform featuring an AI-powered companion robot that incorporates psychology, evidence-based healthcare solutions, and artificial intelligence to help patients better manage their care.

Catalia Health and Mabu provide an interactive companion to patients in order to increase long-term patient engagement.

"We will be commercially launching our platform with renal cell cancer patients this fall. Catalia Health is currently raising our third round of funding to enable the company to extend our platform into additional disease states and to improve the interactions in the core platform. Selection as a finalist will help in funding those efforts. In addition to the prize money, the opportunity to present our innovation to the larger global cancer community would be extremely helpful in creating greater awareness of our product and expanding our outreach to the cancer community."

Watch his 2017 application video.

Charlotte Vander Stichele

2017 First Prize Winner

Charlotte Vander Stichele, Antwerp, Belgium

Charlotte is a graphic designer for MindBytes, whose Cancer Patient Decision Aid (CADA) would provide patients with a visually engaging and interactive scenario-based decision-support tool complete with information on disease burden, treatment impacts, and the various decision-points during care.

CADA is designed to allow patients to work with their doctors and feel more empowered over the course of their treatment.

"We aim to use the Astellas Oncology C3 Prize to develop and clinically test CADA innovative approach towards treatment decision-making. We will engage patients and physicians at the Universities of Uppsala (Sweden) and Leuven (Belgium) through face-to-face interviews and focus groups, in order to construct scenarios that closely reflect the reality of oncology patients."

Watch her 2017 application video.

2016 Winners

Mark Harrison

2016 First Prize Winner

Mark Harrison, Melbourne, Australia
Australian Prostate Cancer Research

As CEO of Australian Prostate Cancer Research, Mark Harrison recognizes that for many men with prostate cancer—particularly those living in remote and rural communities—accessing appropriate support and clinical services can be challenging.

This knowledge inspired him to develop PROSTMATE, one of the world’s first interactive online systems designed to meet the needs of men with prostate cancer. A membership-based program, PROSTMATE provides a tailored experience to help men with prostate cancer get the information, support, and tools they need to manage their disease.

"The C3 Prize has assisted us in the area of marketing and distribution of our platform to a diverse consumer base. By leveraging this expertise, we are building a distribution strategy that is significantly enhancing the reach and range of PROSTMATE."

Watch his 2016 application video.

Larry Pederson

2016 First Prize Winner

Larry Pederson, Seattle, Washington
The Litebook Company Ltd

As a longtime sufferer of seasonal affective disorder (SAD), Larry Pederson was driven to find a better solution for existing lightbox technology. In 2000, he founded The Litebook Company, a Canadian-based organization that invented a portable light therapy device called The Litebook®.

The Litebook holds promise for cancer patients suffering from the profound fatigue often brought on by chemotherapy treatment—a symptom that is similar in many ways to the feeling that results from severe jet lag. In much the same way that the Litebook can reset a traveler’s internal body clock, the device has the potential to “reset” a patient’s body clock and help to improve energy, sleep, and overall quality of life.

"Grant funding and publicity from the C3 Prize are helping to raise awareness of Litebook as a simple tool to improve the quality of life for cancer patients undergoing chemotherapy. More specifically, funding is helping us implement an education and awareness campaign targeting cancer societies, oncologists' organizations and related cancer treatment entities, cancer research foundations and cancer patient support networks."

Watch his 2016 application video.

Learn details about C3 Prize